logo
  

Shaw Communications Q2 Profit Declines

Shaw Communications Inc. (SJR) announced 9.7 percent decline in second-quarter net profit, while revenues were down 2.0 percent from the previous year.

The company recorded a quarterly net income of C$196 million, down from C$217 million in the previous month. On a per-share basis, earnings were C$0.39, down from C$0.43 in the same quarter last year. Second-quarter wireless ARPU declined 1.1 percent from the prior year. Subscriber growth in wireless services supported a revenue increase of 9.2 percent in that segment.

The Canadian telecommunication company added approximately 16,900 new Wireless customers in the second quarter. Postpaid net additions were approximately 8,600.

Further, the company noted that regulatory approval for a combination of Rogers and Shaw is obtained. The closing of the transaction is expected in the first half of 2022.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Amazon has unveiled millions of deals worldwide that will be available during its upcoming Prime Day extravaganza. The 48-hour shopping event for Prime members kicks off July 12 at 3 a.m. EDT, offering deals of up to 79% off across various categories. These include electronics, devices, toys, beauty, fashion, and home, from top national brands and small businesses. Primal Pet Foods is recalling a single lot of Raw Frozen Primal Patties for Dogs Beef Formula due to potential contamination with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recall involves lot #W10068709 of 6-pound Raw Frozen Primal Patties with best by date of 05/22/23. The Raw Frozen Primal Patties are sold in flexible packaging in the freezer at select pet stores. The U.S. Food and Drug Administration has authorized state-licensed pharmacists to prescribe COVID-19 pill Paxlovid (nirmatrelvir and ritonavir) by drug major Pfizer Inc. to eligible patients, with certain limitations. The agency has revised the Emergency Use Authorization or EUA for Paxlovid for the authorization, which could improve access for some patients at high risk for severe covid-19.
Follow RTT